Joslin Kidney Panel of Circulating Proteins
Andrzej S. Królewski(Joslin Diabetes Center), Alessandro Doria(Harvard University), Youngshin Keum(Joslin Diabetes Center), Hiroki Kobayashi(Nihon University), Marlon Pragnell(Breakthrough T1D), Zaipul I. Md Dom(Joslin Diabetes Center), Tarunveer S. Ahluwalia(Steno Diabetes Centers), Fergus Fleming(Dialyse Centrum Groningen), Per‐Henrik Groop(University of Helsinki), Jani K. Haukka(University of Helsinki), Sathishkumar Baskaran(Uppsala University), Monika A. Niewczas(Joslin Diabetes Center), Niina Sandholm(University of Helsinki), Valma Harjutsalo(Research Council of Finland), Sok Cin Tye(Joslin Diabetes Center), Simone Theilade(Steno Diabetes Centers), Viktor Rotbain Curovic(Steno Diabetes Centers), Stefan Mutter(University of Helsinki), Peter Rossing(Steno Diabetes Centers), Mario Luca Morieri(Joslin Diabetes Center), Robert G. Nelson(Joslin Diabetes Center), Joseph V. Bonventre(Brigham and Women's Hospital), Andrzej T. Gałecki(University of Michigan), Eiichiro Satake(Joslin Diabetes Center), Narges Rashidi(Olink (United States)), Katsuhito Ihara(Tokyo Medical and Dental University)
Cited by 3
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients
|Journal of the American Society of Nephrology|2005|3.4k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k